Latest Insights on REGN

May 3, 2022 Stock Power Daily
Among the most lucrative mega trends of the next decade, biotech is poised to grow revenues 77% by 2026. This Power Stock has been on the front lines of the battle against COVID-19 and rates a 96 on our proprietary system.
February 23, 2022 Money Moves
Carl Icahn, world-renowned investor—and apparently an avid animal lover—is threatening McDonald's over its treatment of the pigs used by its suppliers.
February 21, 2022 Investing
Do you want to be a biotech value investor? It's possible to target solid companies trading at cheaper valuations in tech sectors.
February 6, 2022 Investing
In this week's Earnings Edge: Fiserv Inc. (Nasdaq: FISV) and Expedia Group Inc. (Nasdaq: EXPE) could head in different directions post-call.
January 30, 2022 Investing
Regeneron Pharmaceuticals (Nasdaq: REGN) and Sirius XM Holdings (Nasdaq: SIRI) stocks are set to break out. Keep an eye on earnings.